According to Venus Remedies latest financial reports the cash on hand of VENUSREM is $8.51M, an increase of 57.46% to 2022. At the end of 2022 company had $5.40M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $8.51M | 57.46% |
2022 | $5.40M | 54.88% |
2021 | $3.49M | 1406.14% |
2020 | $231.56K | -4.46% |
2019 | $242.37K | - |